Latest Articles

Publication Date
All News Scientific
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …

Published: May 20, 2024, 7 a.m.
Read Full Article
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer - Hospital Healthcare

Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer Hospital Healthcare

Published: March 14, 2024, 7 a.m.
Read Full Article
GSK’s Jemperli combination recommended by NICE as first-line endometrial cancer treatment - PMLiVE

GSK’s Jemperli combination recommended by NICE as first-line endometrial cancer treatment PMLiVE

Published: March 5, 2024, 8 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!